Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.18 +0.54 (+4.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Accounts Payables (2012 - 2026)

Updated

Enanta Pharmaceuticals' Accounts Payables came in at $3.29 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 7.2% from $3.55 million a year earlier and down 24.5% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Accounts Payables (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Accounts Payables was $1.95 million, down 75.7% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
  • Going back by fiscal year, Accounts Payables was $8 million in FY2024 (+95.3%), $4.1 million in FY2023 (-31.7%), $6 million in FY2022 (-37.1%) and $9.54 million in FY2021 (+66.3%).
  • The five-year range for quarterly Accounts Payables is $1.25 million (fiscal Q3 2022) to $11.76 million (fiscal Q2 2023).
  • Year-over-year, Accounts Payables has declined for seven consecutive quarters, with an average decline of 25.2% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in fiscal Q3 2023 (growth of 537.1%), and the weakest in fiscal Q3 2022 (a decline of 78.9%).
  • Business Quant data shows ENTA's Accounts Payables at $4.36 million (Q2 2026), $1.89 million (Q1 2026) and $1.95 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Enanta Pharmaceuticals 383.80 Mn -344.19 Mn - 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.29 Mn
Mar 31, 2026 4.36 Mn
Dec 31, 2025 1.89 Mn
Sep 30, 2025 1.95 Mn
Jun 30, 2025 3.55 Mn
Mar 31, 2025 4.76 Mn
Dec 31, 2024 4.73 Mn
Sep 30, 2024 8.00 Mn
Jun 30, 2024 10.68 Mn
Mar 31, 2024 6.73 Mn
Dec 31, 2023 9.33 Mn
Sep 30, 2023 4.10 Mn
Jun 30, 2023 7.93 Mn
Mar 31, 2023 11.76 Mn
Dec 31, 2022 4.35 Mn
Sep 30, 2022 6.00 Mn
Jun 30, 2022 1.25 Mn
Mar 31, 2022 5.99 Mn
Dec 31, 2021 7.84 Mn
Sep 30, 2021 9.54 Mn
API Access

Enanta Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENTA&period=max&api_key=YOUR_API_KEY